Funding benchmark · last 12 months

The typical Series A round in Biotech

From 67 Series A rounds announced in Biotech over the last twelve months, each read from a named source. Half of them raised between $17M and $59M.

See the roundsAll benchmarks

Series ABiotech
Median round$32M
$7.6M1 in 10 below$17M – $59Mmiddle half$107M1 in 10 above

67 rounds counted · recounted nightly

Rounds counted67Series A rounds in Biotech, last 12 months
Against worldwide+60%vs the $20M worldwide median
Since last round22 momedian gap, from 14 companies we saw raise before
Lead named78%of these rounds name the investor who led

The trend

Median Series A round, quarter by quarter

From $12M in 2024 Q4 to $32M in 2026 Q3. Quarters with fewer than five rounds are left blank.

$12M'24 Q48 rds
$16M'25 Q112 rds
$33M'25 Q210 rds
$45M'25 Q38 rds
$29M'25 Q415 rds
$25M'26 Q19 rds
$35M'26 Q223 rds
$32M'26 Q312 rds

Who leads

The most active leads

The firms that led the most Series A rounds in Biotech this year.

  1. 1Sofinnova Partners2 led
  2. 2Omega Funds2 led
  3. 3Highland Europe2 led
  4. 4Andera Partners2 led
  5. 5Frazier Life Sciences2 led
  6. 6New Rhein2 led

Recent examples

Series A rounds in Biotech, latest first

How to read these figures

They come from announced rounds. Large rounds are almost always announced and many small ones never are, so the true typical round is probably a little smaller than shown, most of all at pre-seed and seed. Every round behind them is in the record with its source. How we read rounds.

Other stages in Biotech

Seed$7.3MSeries B$63M

Series A elsewhere

AI$21MUnited States$25MFintech$16MHealthcare$20MUnited Kingdom$14MRobotics$28MConstruction$23MCybersecurity$25MBig Data & Analytics$21MSoftware$18MEnergy$26MManufacturing$19MEnterprise Software$21MIndia$10MLogistics$13MDefence Tech$25MHardware & Electronics$25MFinancial Services$20MClimate Tech$15MAustralia$15MHealthtech$13MSaaS$17M

Raising a Series A round?

See who leads rounds like yours,
and check your raise before you pitch.

Take the Fundability TestOr find investors

Q&A

How big is a typical Series A round in Biotech?

The median is $32M, from 67 Series A rounds announced in Biotech in the last twelve months. Half of them raised between $17M and $59M; one in ten raised more than $107M.

Which rounds are counted?

Rounds announced in the last twelve months with a stated amount and stage, each read from a named article or filing. A page is only published where at least 30 rounds stand behind it.

Are these figures biased?

Towards larger rounds, yes. Big rounds are announced; many small ones never are. So the true typical round is probably a little smaller than the figure here, especially at pre-seed and seed.

How often does it change?

The figures are recounted from the record every night, as new rounds are read.